A Synthetic Prostaglandin E1 Analog, Alprostadil Alfadex, Relaxes Sphincter of Oddi in Humans

Nebel OT: Manometric evaluation of the papilla of Vater. Gastrointest Endosc 21:126–128, 1975 Geenen JH, Hogan WJ, Dodds WJ, Stewart ET, Arndorfer C: Intraluminal pressure recording from the human sphincter of Oddi. Gastroenterology 78:317–324, 1980 Staritz M, Meyer zum Buschenfelde KH: Investigation of the effect of diazepam and other drugs on the sphincter of Oddi motility. Ital J Gastroenterol 18:41, 1986 Staritz M: Pharmacology of the sphincter of Oddi. Endoscopy 20:171–174, 1988 Allescher HD, Neuhaus H, Hagenmuller F, Classen M: Effect of N-butylscopolamine on sphincter of Oddi motility in patients during routine ERCP—a manometric study. Endoscopy 20:73, 1988 Kaczor R, Nowakowska-Dulawa E, Rybicka J: Effects of scopolamine butylbromide, papaverine and glucagon on the sphincter of Oddi motility. Endoscopy 20:73, 1988 Staritz M, Poralla T, Ewe K, Meyer zum Buschenfelde KH: Effect of glyceryl trinitrate on the sphincter of Oddi motility and baseline pressure. Gut 26:194–197, 1985 Luman W, Pryde A, Heading RC, Palmer KR: Topical glyceryl trinitrate relaxes the sphincter of Oddi. Gut 40:541–543, 1997 Guelrud M, Mendoza S, Rossiter G, Ramirez L, Barkin J: Effect of nifedipine on sphincter of Oddi motor activity: Studies in healthy volunteers and patients with biliary dyskinesia. Gastroenterology 95:1050–1055, 1988 Fullarton GM, Falconer S, Campbell A, Murray WR: Controlled study of the effect of nicardipine and ceruletide on the sphincter of Oddi. Gut 33:550–553, 1992 Szczeklik A, Gryglewski RJ: Prostaglandins in therapy of cardiovascular disease. Adv Prostaglandin Thromboxane Leukot Res 13:345–354, 1985 Porst H, Buvat J, Meuleman E, Michal V, Wagner G: Intracavernous alprostadil alfadex—an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study. Int J Impot Res 10:225–231, 1998 Okazaki K, Yamamoto Y, Ito K: Endoscopic measurement of papillary sphincter zone and pancreatic main ductal pressure in patients with chronic pancreatitis. Gastroenterology 91:409–418, 1986 Takaaki J, Akaki H, Furuya S, Morita M, Fukui Y, Sato T, Fukuda S, Kodama T, Kashima K: Effect of cisapride on the motor activity of the sphincter of Oddi in humans: Evaluation by endoscopic biliary manometry. Adv Ther 11:177–182, 1994 Sato H, Kodama T, Takaaki J, Tatsumi Y, Maeda T, Fujita S, Fukui Y, Ogasawara H, Mitsufuji S: Endoscopic papillary balloon dilatation may preserve sphincter of Oddi function after common bile duct stone management: evaluation from the viewpoint of endoscopic manometry. Gut 41:541–544, 1997 Toouli J, Roberts-Thompson IC, Dent J, Lee J: Manometric disorders in patients with suspected sphincter of Oddi dysfunction. Gastroenterology 88:1243–1250, 1985 Guelrud M, Mendoza S, Rossiter G, Villegas MI: Sphincter of Oddi in healthy volunteers. Dig Dis Sci 35:38–46, 1990 Bennett A, Fleshler B: Prostaglandins and the gastrointestinal tract. Gastroenterology 59:790–800, 1970 Waller SL: Prostaglandins and the gastrointestinal tract. Gut 14:402–417, 1973 Eberhart CE, Dubois RN: Eicosanoids and the gastrointestinal tract. Gastroenterology 109:285–301, 1995 Ishizawa M: Contractile effects of PGD2 and PGFβ2 on mechanical and electrical activities in longitudinal and circular muscles of the guinea-pig colon. Prostaglandins 26:175–186, 1983 Sinar DR, Fletcher JR, Castell DO: Prostaglandin E1 effects on resting and cholinergically stimulated lower esophageal sphincter pressure in cats. Prostaglandins 21:581–590, 1981 Rattan S, Hersh T, Goyal RK: Effect of prostaglandin Fβ2 and gastrin pentapeptide on the lower oesophageal sphincter. Proc. Soc Exp Biol Med 141:573–575, 1972 Tollstrom T, Hellstrom PM, Johansson C, Pernow B: Effects of prostaglandins E2 and F2α on motility of small intestine in man. Dig Dis Sci 33:552–557, 1988 Konturek SJ, Thor P, Pawlik W, Gustow P, Dembinski A: Role of prostaglandins in the myoelectric, motor and metabolic activity of the small intestine in the dog. In Motility of the Digestive Tract. M Weinbeck (ed). New York, Raven Press, 1982, pp 437–444 Behar J, Biancani P: Neural control of the sphincter of Oddi: A physiological role of 5-hydroxytryptamine on the regulation of basal sphincter of Oddi motor activity in the cat. J Clin Invest 72:551–559, 1983 Sarles JC: Hormonal control of sphincter of Oddi. Dig Dis Sci 31:208–212, 1986 Funch-Jensen P, Ebbehoj N: Sphincter of Oddi motility. Scand J Gastroenterol 31:46–51, 1996 Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM, Herman AG: Nitric oxide as an inhibitory nonadrenergic non-cholinergic neurotransmitter. Nature 345:346–347, 1990 Behar J, Biancani P: Pharmacologic characterisations of excitatoty and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi. Gasroenterology 92:764–770, 1987 Andersson KE, Andersson R, Hedner P, Persson CGA: Parallelism between mechanical and metabolic responses to cholecystokinin and prostaglandin E2 in extrahepatic biliary tract. Acta Physiol Scand 89:571–579, 1973 Nakano J, McCloy RE, Gin AC, Nakano SK: Effect of prostaglandins E1, E2 and Fβ2, and pentagastrin on the gall bladder pressure in dogs. Eur J Pharmacol 30:107–112, 1975 Martinez E, Sarles JC: Effect of prostaglandins E1, E2 and Fβ2 on the electric activity of the sphincter of Oddi in living rabbit. Eur Surg Res 15:322–327, 1983 Brandstatter G, Schinzel S, Wurzer H: Influence of spasmolytic analgesics on motility of sphincter of Oddi. Dig Dis Sci 41:1814–1818, 1996 Donnellan I, Hallissey M, Nwokolo C, Loft D, Fraser I: Sublingual GTN spray improves success at ERCP cannulation. Gut 35:S36, 1994 (abstract) Staritz M, Poralla T, Dormeyer HH, Meyer zum Buschenfelde KH: Endoscopic removal of common bile duct stones through the intact papilla after medical sphincter dilation. Gasroenterology 88:1807–1811, 1985 Sand J, Nordback I, Koskinen M, Matikainen M, Lindholm TS: Nifedipine for suspected type II sphincter of Oddi dyskinesia. Am J Gastroenterol 88:530–535, 1993